Early research (Phase 1)Study completedNCT03656705What this trial is testingCCCR-NK92 Cells Immunotherapy for Non-small Cell Lung CarcinomaWho this might be right forNon-small Cell Lung Cancer Henan Medical University 2
Not applicableStudy completedNCT03107156What this trial is testingUnderstanding Evidence-Based Practice Patterns in Advanced NSCLCWho this might be right forNon Small Cell Lung Cancer Carevive Systems, Inc. 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07294261What this trial is testingGarsorasib In KRAS G12C Mutant Locally Advanced and Metastatic NSCLCWho this might be right forLocal Advanced or Metastatic NSCLC Sun Yat-sen University 69
Post-approval studies (Phase 4)Study completedNCT01287754What this trial is testingTarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Who Present EGFR MutationsWho this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 24
Testing effectiveness (Phase 2)Study completedNCT00019331What this trial is testingVaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsWho this might be right forColorectal CancerEndometrial CancerHead and Neck Cancer+6 more National Cancer Institute (NCI)
Large-scale testing (Phase 3)Ended earlyNCT01379976What this trial is testingAcetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Mario Negri Institute for Pharmacological Research 107
Early research (Phase 1)Ended earlyNCT06714617What this trial is testingEvaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid TumorsWho this might be right forBreast Cancer Stage IIIHER2-positive Metastatic Breast CancerUnresectable Breast Carcinoma+11 more SystImmune Inc. 3
Large-scale testing (Phase 3)Study completedNCT03922997What this trial is testingInvestigate the Safety and Efficacy of Atezolizumab in Previously-Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Hoffmann-La Roche 101
Early research (Phase 1)Study completedNCT01783197What this trial is testingStudy of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLCWho this might be right forNon Small Cell Lung Cancer Canadian Cancer Trials Group 39
Not applicableActive Not RecruitingNCT03969823What this trial is testingWhole Genomic Landscape of Advanced EGFR-mutant NSCLCWho this might be right forLocally Advanced or Metastatic NSCLC Seoul National University Hospital 148
Large-scale testing (Phase 3)Study completedNCT01456325What this trial is testingOnartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Participants With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have Received Chemotherapy For Advanced or Metastatic Disease (MetLung)Who this might be right forNon-Squamous Non-Small Cell Lung Cancer Genentech, Inc. 494
Not applicableActive Not RecruitingNCT06808113What this trial is testingCirculating and Molecular Markers Involved in the Processes of Cachexia, Anorexia and Sarcopenia in Patients With NSCLCWho this might be right forNon Small Cell Lung Cancer IRCCS Azienda Ospedaliero-Universitaria di Bologna 40
Testing effectiveness (Phase 2)Looking for participantsNCT07486817What this trial is testingBeamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without PembrolizumabWho this might be right forLung Cancer, Non-squamous, Non-small Cell Boehringer Ingelheim 60
Early research (Phase 1)Active Not RecruitingNCT02609776What this trial is testingStudy of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung CancerWho this might be right forNon-Small-Cell Lung Cancer Janssen Research & Development, LLC 751
Testing effectiveness (Phase 2)Ended earlyNCT04856176What this trial is testingSargramostim Plus Pembrolizumab with or Without Pemetrexed in Patients with Advance Non-small Cell Lung Cancer After Completion of ChemoimmunotherapyWho this might be right forAdvanced Lung Non-Small Cell CarcinomaNon-Small Cell Carcinoma of Lung, TNM Stage 4 Tufts Medical Center 5
Large-scale testing (Phase 3)Ended earlyNCT00633568What this trial is testingRandomised Study of Concomitant Radiochemotherapy in Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Carcinoma European Lung Cancer Working Party 125
Testing effectiveness (Phase 2)Active Not RecruitingNCT04995523What this trial is testingAZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLCWho this might be right forNon-Small-Cell Lung Carcinoma AstraZeneca 212
Large-scale testing (Phase 3)UnknownNCT05673590What this trial is testingUtidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerWho this might be right forLocally Advanced or Metastatic Non-Small Cell Lung Cancer Beijing Biostar Pharmaceuticals Co., Ltd. 612
Testing effectiveness (Phase 2)Study completedNCT00005989What this trial is testingR115777 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung CancerWho this might be right forLung Cancer Mayo Clinic
Testing effectiveness (Phase 2)Ended earlyNCT00313768What this trial is testingRandomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLCWho this might be right forCarcinoma, Non-Small-Cell Lung Pfizer 23